C 455
Alternative Names: C-455Latest Information Update: 04 Feb 2021
At a glance
- Originator AstraZeneca
- Class Hepatoprotectants; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic steatohepatitis
Most Recent Events
- 21 Sep 2020 Preclinical trials in Non-alcoholic steatohepatitis in United Kingdom (IV)
- 21 Sep 2020 Preclinical trials in Non-alcoholic steatohepatitis in United Kingdom (PO)
- 21 Sep 2020 Pharmacodynamics and pharmacokinetics data from preclinical studies in Non-alcoholic steatohepatitis presented at the 56th Annual Meeting of the European Association for the Study of Diabetes (EASD-2020)